Another pharma leader joins our partner ecosystem, we welcome AstraZeneca as they bring their vast industry experience and insights from their own digital transformations!

AstraZeneca is a global biopharmaceutical company engaged in the research, development, and marketing of ethical drugs. Science has always been in AstraZeneca’s DNA committed to broadening its horizons to develop drugs that can significantly improve the lives of patients. By discovering and co-developing digital health solutions, they have the potential to drive the shift-change in healthcare that is needed to diagnose and detect disease sooner, manage risks and help slow or potentially prevent disease onset.

During this year’s conference, they will run a session alongside Gemelli Digital Medicine and Health Srl (GDMH), titled “Digital Health Solutions: when private-public partnerships can make the difference”.

Gemelli Digital Medicine and Health Srl (GDMH) is a Prime Integrator of Digital Medicine & Health Products and Services through co-creation and co-development strategies. GDMH exploits the full potential of the knowledge base and clinical expertise of Fondazione Policlinico Universitario A. Gemelli IRCCS while promoting the Hospital as a global player in Digital Health.

To go in-depth and discover more about private-public partnerships in digital health, join the AstraZeneca curated session at #FH22, by registering here